Whale Team

[Goodmooring]

A few things that make you question HOW this is a .007 sub penny stock..

1. Multiple Pharm prodrug Patents until 2034
2. Licensing agreements with another Pharm company worth 10's of millions 9/2018
3. Continued verifiable ongoing research in Denmark, Germany, Australia and The USA. 2/2019
4. Military research involvement 11/2018
5. Samuel Denmeade, John Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center, Department of Defense Prostate Cancer Research Program/Military Clinical Pipeline
6. Sabby Hedge fund, Hal Mintz - ownership investment 11/2018
7. JLL one of the world's leading investment managers, Connor Flannery - ownership investment 11/2018
8. Soren Christensen - University of Copenhagen - Continued research latest publication submitted in Dec 2018 Published in January 2019.
9. FDA - Orphan Drug Status for Mipsagargin
10. WHO’s International Nonproprietary Name group or the INN recommended the generic name “mipsagargin” for Inspyr's lead compound G-202
11. "Perhaps one of the most important studies" This is how Mipsagargin is being PUBLISHED in 2019!!! https://www.mdpi.com/2072-6694/11/2/145/htm
Article Received: 21 December 2018 / Accepted: 23 January 20

Going to take off with the impending SEC filings!!

$NSPX STRONGER


"Perhaps one of the most important studies"
Goodmooring on 3/10/2019 2:41:33 PM



Report TOS